Advanced Proteome Therapeutics Corporation
APTCF
$0.0002
-$0.0365-99.46%
OTC PK
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -431.62% | -32.57% | -175.20% | 83.71% | -174.51% |
| Total Depreciation and Amortization | -91.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29,620.00% | 93.75% | 65.91% | -199.53% | 123.97% |
| Change in Net Operating Assets | -234.75% | 191.30% | -23.58% | 61.64% | -70.15% |
| Cash from Operations | -141.28% | 39.52% | -4.12% | -3.57% | -72.18% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 811.97% | -- | -- | -- | -- |
| Cash from Investing | 478.49% | -- | -- | -- | -- |
| Total Debt Issued | 2.22% | -- | -- | -233.87% | 195.22% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -94.44% | -- | -- | -97.11% | -7.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -162.12% | 67.50% | -6.95% | -1,822.12% | -111.97% |